Published in J Invest Dermatol on February 17, 2015
The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol (1986) 3.06
Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol (2011) 2.27
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol (1971) 1.57
Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. J Dermatol Sci (2011) 1.51
Pemphigoid diseases. Lancet (2012) 1.47
Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol (1997) 1.41
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest (2005) 1.38
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Epidermolysis bullosa acquisita: what's new? J Dermatol (2010) 1.28
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Epidermolysis bullosa acquisita. Clin Dermatol (2011) 1.14
Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol (2002) 1.07
Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol (2006) 1.03
High-affinity binding of the NC1 domain of collagen VII to laminin 5 and collagen IV. Biochem Biophys Res Commun (2006) 1.02
Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol (2002) 1.01
NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol (2007) 1.01
Epidermolysis bullosa acquisita--a pemphigoid-like disease. J Am Acad Dermatol (1984) 0.99
Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol (2005) 0.98
Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol (2006) 0.97
IgG4 autoantibodies induce dermal-epidermal separation. J Cell Mol Med (2007) 0.94
Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol (1993) 0.94
Emerging treatments for pemphigoid diseases. Trends Mol Med (2013) 0.94
Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J Immunol (1995) 0.93
Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol (2004) 0.92
Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. J Invest Dermatol (1995) 0.92
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. J Pathol (2012) 0.91
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. J Am Acad Dermatol (2012) 0.89
The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol (1991) 0.89
Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. J Invest Dermatol (2012) 0.88
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatol (2013) 0.88
The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. Am J Pathol (2007) 0.88
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. J Invest Dermatol (1986) 0.88
Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J Immunol (2011) 0.86
B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. J Immunol (2013) 0.86
Keratinocyte-/fibroblast-targeted rescue of Col7a1-disrupted mice and generation of an exact dystrophic epidermolysis bullosa model using a human COL7A1 mutation. Am J Pathol (2009) 0.85
Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII. Cell Mol Life Sci (2010) 0.85
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol (1989) 0.84
The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. Br J Dermatol (2011) 0.83
Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci (2005) 0.83
Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol (1994) 0.83
Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol (1994) 0.83
Epidermolysis bullosa acquisita--a sign of cicatricial pemphigoid? Br J Dermatol (1979) 0.81
Blocking Fcα receptor I on granulocytes prevents tissue damage induced by IgA autoantibodies. J Immunol (2012) 0.81
Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J Autoimmun (2009) 0.80
Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol (1991) 0.80
Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol (2009) 0.79
Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo. J Immunol (2014) 0.78
Model systems duplicating epidermolysis bullosa acquisita: a methodological review. Autoimmunity (2011) 0.78
Insight into interactions of the von-Willebrand-factor-A-like domain 2 with the FNIII-like domain 9 of collagen VII by NMR and SPR. FEBS Lett (2011) 0.78
Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Derm Venereol (2011) 0.77
Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol (2000) 0.77
Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol (2014) 1.47
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid. J Invest Dermatol (2016) 1.43
Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population. Exp Dermatol (2015) 1.41
A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. J Immunol (2010) 0.83
Erythema annulare centrifugum-like mycosis fungoides after unrelated bone marrow transplantation. Br J Haematol (2015) 0.82
Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. Eur J Immunol (2015) 0.81
Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease. Exp Dermatol (2013) 0.80
IgE-specific immunoadsorption for treatment of recalcitrant atopic dermatitis. JAMA Dermatol (2014) 0.79
RNA recognition motif of LEMD3 as a key player in the pathogenesis of Buschke-Ollendorff syndrome. J Dermatol Sci (2015) 0.78
Malignancies in pemphigus and pemphigoid diseases. J Invest Dermatol (2015) 0.78
Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases. Exp Dermatol (2015) 0.78
Plasma cell cheilitis extending beyond vermillion border. J Dermatol (2015) 0.77
A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial. Health Technol Assess (2017) 0.77
Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita. PLoS One (2013) 0.77
Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. Exp Dermatol (2015) 0.77
Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita. J Invest Dermatol (2014) 0.77
Dimethylfumarate Impairs Neutrophil Functions. J Invest Dermatol (2016) 0.76
Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Am J Pathol (2014) 0.76
In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury. Exp Dermatol (2016) 0.76
Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab. J Dermatol (2015) 0.75
A novel NCSTN mutation alone may be insufficient for the development of familial hidradenitis suppurativa. J Dermatol Sci (2014) 0.75
Basal Cell Carcinoma or Trichoblastoma? Dermoscopic Examination of Black Macules Developing in the Same Nevus Sebaceus. Case Rep Oncol (2016) 0.75
Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet (2017) 0.75
Quality of Life Assessment in Korean Patients with Pemphigus. Ann Dermatol (2015) 0.75
A Rare Case of a Symptomatic Tumor Found in the Groin Area: An Atypical Location Unexposed to the Known Causes. Case Rep Oncol (2015) 0.75
Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model. Clin Immunol (2011) 0.75
From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases. J Invest Dermatol (2014) 0.75
Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C. Lab Invest (2016) 0.75
Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting. Indian J Dermatol (2016) 0.75
Recurrence of juvenile dermatomyositis 8 years after remission. JAAD Case Rep (2016) 0.75
Homozygous Deletion Mutation of the FERMT1 Gene in a Chinese Patient with Kindler Syndrome. Ann Dermatol (2016) 0.75
A palindromic motif in the -2084 to -2078 upstream region is essential for ABCA12 promoter function in cultured human keratinocytes. Sci Rep (2014) 0.75
A Case of Pemphigus Herpetiformis with Only Immunoglobulin G Anti-Desmocollin 3 Antibodies. Ann Dermatol (2016) 0.75
EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils. PLoS One (2014) 0.75
Filaggrin Mutation in Korean Patients with Atopic Dermatitis. Yonsei Med J (2017) 0.75
Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita. J Invest Dermatol (2014) 0.75
Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3. J Dermatol (2016) 0.75
Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus. J Invest Dermatol (2017) 0.75
Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus. Int J Dermatol (2017) 0.75
Generalized Netlike Erythema and Stroke in a Young Female. JAMA Dermatol (2017) 0.75
Hemosiderotic histiocytoma associated with chronic traumatic stress in a patient with spinal cord injury. J Dermatol (2015) 0.75
Late-onset skin involvement on the forehead in multicentric Castleman disease. Int J Dermatol (2017) 0.75
Seborrheic keratosis arising on an epidermal nevus with HRAS p.G13R mutation. Int J Dermatol (2017) 0.75
A case of papular elastolytic giant cell granuloma: A mini-review of reported cases. Eur J Dermatol (2015) 0.75
Localized pemphigus vulgaris clinically masquerading as lichen planus and actinic keratosis. J Dermatol (2015) 0.75
Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. J Invest Dermatol (2016) 0.75
Case of phenylephrine hydrochloride-induced periorbital contact dermatitis with fulminant keratoconjunctivitis causing pseudomembrane formation. J Dermatol (2017) 0.75
Kimura disease associated with severe visual dysfunction due to remarkable periorbital involvement. J Dermatol (2015) 0.75
Experimental laminin 332 mucous membrane pemphigoid critically involves C5aR1 and reflects clinical and immunopathological characteristics of the human disease. J Invest Dermatol (2017) 0.75
In-transit metastasis of advanced eccrine porocarcinoma. Int J Dermatol (2015) 0.75
Low-dose etretinate shows promise in management of punctate palmoplantar keratoderma type 1: Case report and review of the published work. J Dermatol (2015) 0.75
Case of congenital panfollicular nevus with remarkable adipose tissue proliferation. J Dermatol (2016) 0.75
Type XVII collagen coordinates proliferation in the interfollicular epidermis. Elife (2017) 0.75
Keep It Cool: Cryoglobulinemic Purpura. Am J Med (2016) 0.75
Revertant Mosaicism in Ichthyosis with Confetti Caused by a Frameshift Mutation in KRT1. J Invest Dermatol (2016) 0.75
Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion. Front Immunol (2017) 0.75
Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin. Am J Pathol (2015) 0.75
Anti-BP180-type mucous membrane pemphigoid: report of two cases. Odontology (2014) 0.75
Esophagitis dissecans superficialis associated with pemphigus vulgaris. J Dermatol (2015) 0.75
Dermoscopic features of hidroacanthoma simplex: Usefulness in distinguishing it from Bowen's disease and seborrheic keratosis. J Dermatol (2015) 0.75
Clinical and immunological study of mucous membrane pemphigoid in a cohort of Indian patients. Int J Dermatol (2016) 0.75
Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid. J Dermatol Sci (2015) 0.75
Massive petechiae as an initial symptom of Waldenström's macroglobulinemia. Int J Dermatol (2016) 0.75
Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin. Indian J Dermatol Venereol Leprol (2017) 0.75
A case of bullous pemphigoid presenting with severe oedema of the hands during recurrence. Eur J Dermatol (2017) 0.75
Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases. Front Immunol (2017) 0.75
Routine detection of serum anti-desmocollin autoantibodies is only useful in patients with atypical pemphigus. Exp Dermatol (2017) 0.75
Meeting Report of the Pathogenesis of Pemphigus and Pemphigoid Meeting in Munich, September 2016. J Invest Dermatol (2017) 0.75
Cutaneous-type pemphigus vulgaris successfully treated with topical corticosteroids. J Dermatol (2016) 0.75
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity. JAMA Dermatol (2016) 0.75
Chronic papillomatous dermatitis around an ileostoma. J Dermatol (2015) 0.75
Pityriasis Rubra Pilaris Type V as an Autoinflammatory Disease by CARD14 Mutations. JAMA Dermatol (2016) 0.75
Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid. J Am Acad Dermatol (2017) 0.75
Striate palmoplantar keratoderma: Report of a novel DSG1 mutation and atypical clinical manifestations. J Dermatol Sci (2015) 0.75
Hypertrophic lupus erythematosus successfully treated with hydroxychloroquine. J Dermatol (2016) 0.75
Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen. Exp Dermatol (2017) 0.75
Tubular apocrine adenoma clinically and dermoscopically mimicking basal cell carcinoma. J Am Acad Dermatol (2014) 0.75
Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases. Exp Dermatol (2017) 0.75
Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm. Med Mol Morphol (2015) 0.75